Lithium inhibits the catecholamine-dependent cyclic adenosine monophosphate (AMP) generation in the kidney but not the hemodynamic effects of beta-adrenergic stimulation. Therefore, the possible role of catecholamine-dependent cyclic AMP in the release of renin was investigated in lithium-treated dogs both in vivo and in vitro. Lithium therapy had no measurable effect on the increase in plasma renin activity induced by an injection of isoproterenol (2.6 ± 1.2 (SE) ng/hour in control dogs vs. 3.0 ± 1.2 ng/hour in lithium-treated dogs, P > 0.05). However, lithium inhibited the isoproterenol-induced increase in urinary excretion of cyclic AMP in vivo (791 ± 199 pmoles/min in control dogs vs. 123 ± 129 pmoles/min in lithium-treated dogs, P < 0.05) and the increase in cyclic AMP concentration in renal tissue in vitro (4.50 ± 0.15 pmoles/mg wet tissue in control dogs vs. 0.34 ± 0.26 pmoles/mg in lithium-treated dogs, P < 0.01). The finding that, in the lithium-treated dogs, isoproterenol increased plasma renin activity but not cyclic AMP generation in the kidney suggests that the increase in plasma renin activity observed after an injection of isoproterenol is probably not mediated through the beta-adrenergic stimulus-dependent cyclic AMP system in the kidney.
• It has been postulated that in the sympathetic nervous system the beta-adrenergic stimulus plays a role in the regulation of renin secretion (1-7), possibly through the cyclic adenosine monophosphate (AMP) system in the kidney (3, 4, 7, 8) . However, catp:holamines and cyclic AMP are ubiquitous substances (4) , and there are several cyclic AMP systems in the kidney besides the beta-adrenergic stimulus-dependent cyclic AMP system (4) . Furthermore, the release of renin is controlled not only by the renal sympathetic nervous system but also by the vascular receptor in the renal afferent arterioles, the transport of electrolytes at the macula densa, and humoral factors (1, 2) . Therefore, the postulate (3, 4, 7, 8) that the beta-adrenergic stimulus in the kidney increases the release of renin through the cyclic AMP system in the kidney is difficult to evaluate and is controversial (3) (4) (5) (6) (7) (8) . In the present study, the role of the beta-adrenergic stimulus-dependent cyclic AMP system in the kidney on the release of renin was further investigated in dog kidneys.
The beta-receptor blocker, propranolol, inhibits all of the effects of isoproterenol on hemodynamics, cyclic AMP generation in the kidney (8) , and renin From the Department of Medicine, Veterans Administration Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15240.
Received August 16, 1974 . Accepted for publication December 16, 1974. release (6) . Therefore, the use of propranolol does not differentiate between inhibition of renin release through inhibition of hemodynamic changes and inhibition of renin release through inhibition of cyclic AMP generation in the kidney. However, as shown in Results, lithium inhibits the effect of beta-adrenergic stimulation of cyclic AMP generation in the kidney but not that of hemodynamic changes. Therefore, the participation of the catecholamine-dependent cyclic AMP system in the release of renin was reevaluated in lithium-treated dogs.
Methods
Mongrel dogs weighing 14-24 kg were fed regular Purina dog chow. Both the control group and the experimental group of dogs received supplemental NaCl (87 mmoles/day, orally) for 4 days prior to the experiment to expand their extracellular fluid volume. During these 4 days, the dogs were allowed water ad libitum. Lithium chloride (1 mmole/kg day" 1 , orally) was administered for 4 days to the experimental group of dogs. In preliminary experiments, this amount of lithium established a therapeutic plasma concentration of lithium (0.6-1.2 mM) in 4 days. On the day of the experiment, the plasma lithium concentration was measured; only the experimental dogs with a plasma lithium concentration of 0.6-1.2 mM were selected for study. The dogs were anesthetized with sodium pentobarbital (30 mg/kg body weight, iv). Polyethylene catheters were inserted into the femoral arteries to monitor arterial blood pressure and collect blood samples, into a jugular vein to administer infusions, into a femoral vein to collect blood samples, and into the proximal part of each ureter to collect urine samples. Both groups of dogs received 150 mM NaCl at a rate of 2 ml/kg min" 1 for the initial 20 minutes of the experiment and then at 1 ml/kg min" 1 for the next 40 minutes. Then, a second solution containing 75 mM NaCl, 0.5 mg/ml of inulin, and 1.0 mg/ml of paraaminohippuric acid was infused intravenously at the rate of 0.1 ml/kg min" 1 until the end of the experiment. The aortic blood pressure and the heart rate were measured using a Sanborn pressure transducer and an electrocardiograph, respectively, during the experiment.
Dogs were allowed to equilibrate and to stabilize for 60 minutes after the initiation of the second intravenous infusion. Then, three 20-minute urine samples were collected to determine the basal values; blood samples were taken at the middle of each urine collection. Next, isoproterenol (0.02 ng/kg, iv, a submaximum dose), was injected; the injection was followed by 5-, 5-, 10-, and 20-minute urine collections with arterial blood samples taken at the middle of each urine collection. Samples from the vena cava were collected in tubes containing ethylenediaminetetraacetic acid (EDTA) for the measurement of plasma renin activity. The maximum increases in plasma renin activity and urinary cyclic AMP were observed during the initial 20 minutes after the injection of isoproterenol. Therefore, the maximum increase in these values during this 20-minute period was considered as the response to isoproterenol.
Blood concentration of lithium was measured by an atomic absorption spectrophotometer, and plasma renin activity was measured by radioimmunoassay (9) . Lithium (0.1-5 mM) had no measurable effect on the renin assay system. Urinary cyclic AMP was measured by the method of Gilman (10) with modifications (8, 11) . The validity and the precision of the cyclic AMP assay method have been previously described in detail (8, 11) . Lithium or other substances in the urine or tissue specimens had no measurable effect on the cyclic AMP assay system.
In a second series of experiments, dogs were prepared in an identical manner to those used in the first series; their kidneys were then rapidly removed. The cortex and the outer medulla were sliced to a thickness of less than 0.5 mm and a size of 30-50 mg/slice. The slices were then incubated in Krebs-Ringer's-bicarbonate buffer bubbled with a 95% O 2 -5% COj gas mixture; 10 mM theophylline and the study substances were added to the buffer as indicated in Results. After a 10-minute incubation at 37°C, the slices were homogenized at4°C in a glass tissue grinder with 0.5 ml of ice-cold glass-distilled water; the tubes were then placed in a boiling water bath for 3 minutes to terminate the enzyme activity in the homogenate. The tubes were centrifuged at 4°C at 700 g for 15 minutes to precipitate the protein aggregate in the homogenate produced by boiling. The procedure of homogenization required less than 10 seconds for each slice. Cyclic AMP concentration in the supernatant fraction was measured by the method of Gilman (10) with modifications (8, 11) . Sodium and potassium were measured by a flame photometer and chloride by an electrometric titration with silver ions.
Anti-angiotensin I antibody used for the measurement of renin activity was a gift. 1 Synthetic amino-terminal 1-34 fragments of parathyroid hormone were obtained from Beckman Instrument Co., arginine-vasopressin was purchased from Parke-Davis Co., cyclic AMP and adenosine triphosphate (ATP) were purchased from Sigma Chemical Co., and 126 I-angiotensin I and 3 H-cyclic AMP were obtained from New England Nuclear Corp.
Results
In the experimental group of dogs, plasma lithium concentration was 0.90 ± 0.13 (SE) mEq/liter prior to the injection of isoproterenol; there was no measurable change after the isoproterenol injection (0.84 ± 0.12 mEq/liter, P > 0.05, Table 1 ). Plasma concentrations of sodium, potassium, and chloride were not measurably different between the control dogs and the lithium-treated dogs, and these values did not change during the experiment (P > • 0.05, Table 1 ).
There was no measurable change in glomerular filtration rate, effective renal plasma flow, or urinary excretion rates of sodium, potassium, and chloride during the experiment, and these values were not measurably different between the two groups of dogs (P > 0.05, Table 1 ). During the basal period, heart rate and arterial blood pressure were not measurably different between the two groups of dogs (P > 0.05, Table 1 ). Ten to 12 seconds after the intravenous injection of isoproterenol (0.02 /ig/kg)> blood pressure and heart rate were changed in both groups, but these changes were not measurably different between the two groups ( Table 1) .
The basal plasma renin activity was significantly higher in the lithium-treated dogs than it was in the control dogs (P < 0.05, Table 1 ). After the injection of isoproterenol, plasma renin activity was increased both in the lithium-treated dogs and the control dogs. However, these increases were not measurably different between the two groups (P > 0.05, Table 1 ). In contrast, the basal urinary cyclic AMP excretion rate was significantly less in the lithium-treated dogs than it was in the control dogs (P < 0.01, Table 1 ), and the increase in urinary cyclic AMP excretion induced by isoproterenol was abolished in the lithium-treated dogs.
In both renal cortical and medullary slices, the increase in the beta-adrenergic stimulus-dependent cyclic AMP concentration induced by adding 1 fiM isoproterenol to the incubation medium was markedly less in the slices obtained from the 'Generously supplied by Dr. F. Katz, Veterans Administration Hospital, Denver, Colorado. lithium-treated dogs than it was in those obtained from the control dogs (P < 0.01, Table 2 ). However, the parathyroid hormone-dependent cyclic AMP concentration in the cortical slices was not inhibited by the lithium treatment (Table 2 ). In the medullary slices, the vasopressin-dependent cyclic AMP concentration was significantly inhibited by lithium (P < 0.05), but the inhibition was significantly less than that of catecholaminedependent cyclic AMP (P < 0.01).
Discussion
Basal plasma renin activity was significantly higher in the lithium-treated dogs than it was in the control dogs. Lithium has a natriuretic effect (12, 13) and may consequently deplete extracellular fluid volume as well as inhibit antidiuretic effects (14) . Since the major mechanisms modulating the release of renin are the transport of sodium at the macula densa and the intrarenal pressure- Vol. 36, March 1975 sensitive baroreceptor (1, 2) , it is possible that the depletion of the extracellular fluid volume associated with lithium treatment affects the release of renin (15) . To minimize these effects, the extracellular fluid volume was expanded in both groups of dogs by administering 87 mmoles NaCl/day for 4 days prior to the experiments and by infusing 150 mM NaCl (80 ml/kg) for 2 hours prior to the experiment. In these dogs, sodium excretion rate, glomerular filtration rate, and effective renal plasma flow were stable during the entire experiment; the values were not measurably different between the two groups of dogs. Therefore, it is unlikely that the basal plasma renin activity was increased in the lithium-treated dogs by depletion of extracellular fluid volume or diminution of urinary excretion of sodium. However, the possibility that there was an unmeasurable small difference in the extracellular volume between the two groups of dogs-a difference nevertheless suffi- Values are means ± SE for 12 kidneys from each group of dogs; the degree of freedom was 5. * Comparison between the control dogs and the lithium-treated dogs; NS = P > 0.05. t Increase induced by the drug measured by the difference between the basal value and that after drug injection.
$ P < 0.05 in a paired Student's t-test.
cient to affect the plasma renin activity-cannot be excluded in the present experiments. Furthermore, an unmeasurable small diminution of the urinary excretion of sodium in the lithium-treated dogs could have been responsible for the increase in the basal plasma renin activity. Whatever the mechanisms involved in inducing a high basal plasma renin activity in the lithiumtreated dogs, the basal urinary cyclic AMP excretion rate was significantly less in these dogs than it was in the control dogs. Therefore, at least it can be said that the higher basal plasma renin activity in the lithium-treated dogs is probably not due to the augmentation of the catecholamine-dependent cyclic AMP system in the kidney.
Basal values for plasma renin activity and urinary excretion of cyclic AMP do not exclusively represent values induced by catecholamines in the kidney. Other humoral factors, e.g., antidiuretic hormone (1, 2, 16) , can alter plasma renin activity, and an increased filtered load of cyclic AMP (17) or endogenous vasopressin (18) , parathyroid hormone (11) , prostaglandins (18) , orcalcitonin (19) can also increase urinary excretion of cyclic AMP. Therefore, the basal values of plasma renin activity and urinary excretion of cyclic AMP should be interpreted with caution. However, the increase in plasma renin activity or urinary cyclic AMP excretion rate observed after the injection of isoproterenol specifically represents the changes induced by the beta-adrenergic stimulation (2, 8). Lithium had no measurable effect on the change in plasma renin activity induced by isoproterenol. In contrast, it markedly inhibited the increase in urinary excretion of cyclic AMP induced by isoproterenol. The fact that isoproterenol increased plasma renin activity but not cyclic AMP generation in the lithium-treated kidney suggests that the increase in plasma renin activity observed after the injection of isoproterenol is not mediated through the beta-adrenergic stimulus-dependent cyclic AMP system in the kidney.
After the injection of isoproterenol, there was an alteration in pulse pressure but no measurable alteration in mean arterial blood pressure probably due to an expansion of extracellular fluid volume; however, an unmeasurable small change in the pressure augmenting the release of renin cannot be excluded. Most important of all, there was no measurable difference in the hemodynamic changes between the two groups of dogs, even though the catecholamine-dependent cyclic AMP system was markedly inhibited in the lithiumtreated dogs. Therefore, regardless of the mechanism or mechanisms through which isoproterenol increases the release of renin, at least it can be said that the increase in plasma renin activity is not mediated through the cyclic AMP system.
The data in the present experiments neither exclude nor conflict with other hypotheses that extrarenal effects (20) or non-beta-adrenergic effects of isoproterenol augment the release of renin (2-7).
To evaluate whether the changes in urinary Circulation Research, Vol. 36, March 1975 cyclic AMP excretion in both groups of dogs were the result of the changes in the catecholaminedependent cyclic AMP system in the kidney or due to other factors, the effect of lithium on the catecholamine-dependent cyclic AMP system was further evaluated in vitro. In both cortical and medullary slices, cyclic AMP concentrations were increased by isoproterenol, but the increase in cyclic AMP concentration by isoproterenol was significantly less in the slices obtained from the lithium-treated dogs than it was in those obtained from the control dogs. These results are consistent with the in vivo findings and suggest that, in the lithium-treated dogs, the lesser increase in the urinary excretion of cyclic AMP after the injection of isoproterenol is indeed due to the specific inhibition of the catecholamine-dependent cyclic AMP system in the kidney. The anatomical location of the juxtaglomerular apparatus is not clearly demarcated in the kidney. Therefore, the renal cortex and the outer medulla were both studied. In the slices obtained from the control dogs, the increase in cyclic AMP concentration by isoproterenol was significantly less in the cortical slices than it was in the outer medullary slices. These results are comparable to those of another series of experiments (8) .
The inhibitory effect of lithium was greater on catecholamine-depe,ndent cyclic AMP than it was on parathyroid hormone-or vasopressin-dependent cyclic AMP. This result suggests that the inhibitory effect of lithium on the cyclic AMP system is hormonally specific. However, the present series of experiments does not elucidate the inhibitory mechanism of lithium on the catecholamine-dependent cyclic AMP system.
The finding that, in the lithium-treated dogs, isoproterenol increased plasma renin activity but not beta-adrenergic stimulus-dependent cyclic AMP generation in the kidney (urinary cyclic AMP excretion in vivo and cyclic AMP concentration in renal tissue in vitro) suggests that the increase in plasma renin activity observed after the injection of isoproterenol is not mediated through the betaadrenergic stimulus-dependent cyclic AMP system in the kidney.
